ES2031453T3 - Gene-clonas del virus de la enfermedad de newcastle. - Google Patents

Gene-clonas del virus de la enfermedad de newcastle.

Info

Publication number
ES2031453T3
ES2031453T3 ES198686309804T ES86309804T ES2031453T3 ES 2031453 T3 ES2031453 T3 ES 2031453T3 ES 198686309804 T ES198686309804 T ES 198686309804T ES 86309804 T ES86309804 T ES 86309804T ES 2031453 T3 ES2031453 T3 ES 2031453T3
Authority
ES
Spain
Prior art keywords
newcastle disease
disease virus
clones
virus gene
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198686309804T
Other languages
English (en)
Inventor
Richard Walker Bingham
Philip Chambers
Peter Tunley Emmerson
Neil Stewart Millar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Development Corp UK
Original Assignee
National Research Development Corp UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27262863&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2031453(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB858531147A external-priority patent/GB8531147D0/en
Priority claimed from GB868609037A external-priority patent/GB8609037D0/en
Application filed by National Research Development Corp UK filed Critical National Research Development Corp UK
Application granted granted Critical
Publication of ES2031453T3 publication Critical patent/ES2031453T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

EL PROBLEMA DE PROPORCIONAR UN ACCESO RAPIDO A UN POLINUCLEOTIDO CON CODIFICACION DE LA PROTEINA HN Y/O F DEL ARN DEL VIRUS DE LA ENFERMEDAD DE NEWCASTLE SE RESUELVE, DE ACUERDO CON LA INVENCION, RECOMBINANDO LA TECNOLOGIA ADN QUE HA CONDUCIDO A LA CLONACION Y SECUENCIA DE ESTOS GENES. LA INVENCION PROPORCIONA DICHOS POLINUCLEOTIDOS Y, EN PARTICULAR, AQUELLOS DE LA CEPA VIRAL BEAUDETTE C Y OTROS SUFICIENTEMENTE HOMOLOGOS CON ESTO PARA PERMITIR QUE LOS GENES HN Y F DE OTRAS CEPAS SEAN IDENTIFICADOS USANDO BEAUDETTE C DNA COMO MUESTRA. LA INVENCION ES UTIL EN LA DIAGNOSIS DE LA ENFERMEDAD DE NEWCASTLE Y COMO ETAPA PRINCIPAL HACIA LA PRODUCCION DE PROTEINAS VIRICAS PARA USO EN VACUNACION DE AVES.
ES198686309804T 1985-12-18 1986-12-16 Gene-clonas del virus de la enfermedad de newcastle. Expired - Lifetime ES2031453T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB858531147A GB8531147D0 (en) 1985-12-18 1985-12-18 Disease virus gene clones
GB868609037A GB8609037D0 (en) 1986-04-14 1986-04-14 Newcastle disease virus gene clones
US88576586A 1986-07-15 1986-07-15

Publications (1)

Publication Number Publication Date
ES2031453T3 true ES2031453T3 (es) 1992-12-16

Family

ID=27262863

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198686309804T Expired - Lifetime ES2031453T3 (es) 1985-12-18 1986-12-16 Gene-clonas del virus de la enfermedad de newcastle.

Country Status (8)

Country Link
US (1) US5310678A (es)
EP (1) EP0227414B1 (es)
JP (1) JP2534246B2 (es)
AU (1) AU602875B2 (es)
CA (1) CA1319337C (es)
DE (1) DE3679049D1 (es)
ES (1) ES2031453T3 (es)
NZ (1) NZ218630A (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US7767449B1 (en) 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US5174993A (en) * 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
ZA874677B (en) * 1986-06-30 1988-11-30 Smith Kline Rit Dna sequence,recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides,obtained products and preparations containing same
JP2531729B2 (ja) * 1987-03-27 1996-09-04 日本ゼオン株式会社 組み換えアビポックスウイルス
DE3853088T2 (de) * 1987-03-27 1995-10-19 Nippon Zeon Co Rekombinantes Avipoxvirus.
DE10399032I1 (de) * 1987-08-28 2004-01-29 Health Research Inc Rekombinante Viren.
CA1340203C (en) * 1987-09-16 1998-12-15 Noboru Yanagida Recombinant apivoxvirus
US5286639A (en) * 1987-09-16 1994-02-15 Nippon Zeon Co., Ltd. Recombinant avipoxvirus
GB8724885D0 (en) * 1987-10-23 1987-11-25 Binns M M Fowlpox virus promotors
FR2632863B2 (fr) * 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus
FR2622456B1 (fr) * 1987-10-29 1990-02-02 Transgene Sa Virus du fowlpox recombinant, vecteurs d'expression de proteines heterologues et vaccins pour la volaille derives de ce virus
JP2781605B2 (ja) * 1989-06-22 1998-07-30 日本ゼオン株式会社 組み換えアビポックスウイルス
KR960701208A (ko) * 1993-03-16 1996-02-24 엔 엔 데이비스 바이러스 단백질에 의해 면역 반응을 자극하는 방법(stimulation of immune response by viral protein)
WO1994025627A1 (en) 1993-04-30 1994-11-10 Lorence Robert M Methods of treating and detecting cancer using viruses
US5871744A (en) * 1996-09-05 1999-02-16 University Of Maryland-Biotechnology Inst. Method for generating birnavirus from synthetic RNA transcripts
US6231868B1 (en) 1997-09-30 2001-05-15 University Of Maryland-Biotechnology Institute Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts
EP0974660A1 (en) * 1998-06-19 2000-01-26 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Newcastle disease virus infectious clones, vaccines and diagnostic assays
AU4606000A (en) * 1999-06-10 2001-01-02 Agricultural Research Council Vaccine for newcastle disease virus
KR100437888B1 (ko) * 2001-07-30 2004-07-03 주식회사 인트론바이오테크놀로지 뉴캐슬병 바이러스 검출용 프라이머 및 상기 프라이머를이용한 뉴캐슬병 바이러스 검출, 병원성 및 유전형 조사방법
KR100454870B1 (ko) * 2001-07-30 2004-11-03 주식회사 인트론바이오테크놀로지 뉴캐슬병 바이러스의 ｆ 단백질과 ｈｎ 단백질 및 그의유전자들
US8394944B2 (en) * 2002-09-20 2013-03-12 Siemens Healthcare Diagnostics Inc. Dual-purpose primers and probes for providing enhanced hybridization assays by disruption of secondary structure formation
JP2007526215A (ja) * 2003-05-05 2007-09-13 ダウ アグロサイエンス リミテッド ライアビリティー カンパニー トランスジェニック植物細胞に由来する安定な免疫予防的および治療的組成物ならびにその産生方法
CN1293195C (zh) * 2005-09-02 2007-01-03 中国农业科学院哈尔滨兽医研究所 新城疫LaSota疫苗株反向遗传操作系统及其应用
CA2628308A1 (en) 2005-11-04 2007-05-18 Dow Agrosciences Llc Preparation of vaccine master cell lines using recombinant plant suspension cultures
KR100776398B1 (ko) 2006-03-23 2007-11-28 주식회사 고려비엔피 조류 ｈｎ 단백질의 에피토프 및 상기 변이 에피토프를포함하는 뉴캐슬병 바이러스
KR100955502B1 (ko) 2007-11-30 2010-04-30 대한민국 병원성 뉴캐슬병 바이러스 항체와 특이적으로 반응하는펩타이드 및 그의 용도
BR112014009565A2 (pt) 2011-10-21 2017-04-18 Intervet Int Bv vírus da doença de marek não patogênico recombinante, ácido nucleico recombinante, vacina, e, método para ajudar na proteção de um frango contra vírus
EP2768529A1 (en) 2011-10-21 2014-08-27 Intervet International B.V. Recombinant nonpathogenic mdv vector providing multivalent immunity
CN104513317B (zh) * 2013-09-30 2018-12-14 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429965A (en) * 1966-08-01 1969-02-25 Sterling Drug Inc Avian pox virus vaccine and process of preparing same
US4603112A (en) * 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4743553A (en) * 1984-07-18 1988-05-10 W. R. Grace & Co. Synthetic genes for bovine parainfluenza virus
ZA874677B (en) * 1986-06-30 1988-11-30 Smith Kline Rit Dna sequence,recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides,obtained products and preparations containing same

Also Published As

Publication number Publication date
CA1319337C (en) 1993-06-22
EP0227414A2 (en) 1987-07-01
AU602875B2 (en) 1990-11-01
AU6644186A (en) 1987-06-25
US5310678A (en) 1994-05-10
DE3679049D1 (de) 1991-06-06
NZ218630A (en) 1988-08-30
JPS62163693A (ja) 1987-07-20
EP0227414A3 (en) 1988-05-04
JP2534246B2 (ja) 1996-09-11
EP0227414B1 (en) 1991-05-02

Similar Documents

Publication Publication Date Title
ES2031453T3 (es) Gene-clonas del virus de la enfermedad de newcastle.
Chan et al. Chloroplast DNA codes for the primary structure of the large subunit of fraction I protein
ATE451462T1 (de) Klonierung und expression von htlv-iii-dns
MX9202875A (es) Una molecula de dna recombinante y procedimiento para su obtencion.
ES2119776T3 (es) Proteina d- una proteina que une igd de haemophilus influenzae.
ES2147553T3 (es) Vectores virales recombinantes para la expresion en unas celulas musculares.
PT84427B (pt) Processo para a producao de interferoes hibridos uteis como agentes terapeuticos e como intermediarios para a producao de anticorpos bem como de composicoes farmaceuticas que os contem
DE3587840T2 (de) Für das Polypeptid des T-Zellantigenreceptors kodierende Nukleinsäure.
MX9202815A (es) Codificacion del polideoxirribonucleotido, plasmida y procedimiento para preparar un clono que contiene plasmida.
ES2062993T3 (es) Factor de crecimiento humano i semejante a la preproinsulina.
AR016436A1 (es) Proteina que inhibe a la p27, adn que la codifica, anticuerpos y productos de disociacion de los mismos, acido nucleico antisentido, estructura artificialde acido nucleico y la utilizacion de todo esto en terapia y profilaxis de enfermedades
ES2062982T3 (es) Clonaje y expresion del factor de crecimiento de fibroblasto acido.
AR247245A1 (es) Una molecula adn para insertar en una cepa bacteriana gram-negativa que contiene un gen insertado constituido por promotor del complejo nitrogenasa de rhizobium y gen estructural
ES2058486T3 (es) Inmunogenos nativos y recombinantes del grupo b de eimeria tenella utiles como vacunas para las coccidiosis.
ATE130631T1 (de) Verfahren zur isolierung für thymidin-kinase der herpesvirus kodierenden dns.
ES509946A0 (es) Un metodo para aumentar la produccion de proteinas por adn heterologo, en vectores de clonacion de plasmidos.
ES2090357T3 (es) Una proteina de union a colageno asi como su preparacion.
ES2074422T3 (es) Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.
ATE107361T1 (de) Gen des hüllproteins des gurkenmosaikvirus.
ES553374A0 (es) Un procedimiento para mejorar la produccion de un polipeptido deseado en un hospedante transformado con una molecula de adn recombinantes.
ES546597A0 (es) Un procedimiento para preparar un microorganismo hospedante transformado del genero sacharomyces.
CO5280143A1 (es) Mutantes de ehv gm-negativa
ES2045004T3 (es) Procedimiento para la preparacion de proteinas extra\as en estreptomicetos.
ES2107997T3 (es) Procedimiento de uso de vectores de expresion eucarioticos que comprenden el potenciador del virus bk.
ES2037795T3 (es) Procedimiento para la preparacion del antigeno hrpii de plasmodium falciparum sge2.